← Leaderboards
Einar M Sigurdsson
New York University School Of Medicine
$23,612,328
Attributed
$25,644,105
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,644,105 · 10
By mechanism
R01$20,630,429 · 4
RF1$2,438,130 · 1
R21$1,858,055 · 4
R56$717,491 · 1
Top collaborators
- Hyung D Ryoo3 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Fernando Goni$2,364,168
- Susan B Zolla-Pazner$26,881,465
- Jill P Buyon$29,367,681
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposTau ProteinsAntibodiesS DiseaseTau AggregationImmunotherapyClinical TrialsBrainNeuronsIn VivoPathologyMouse ModelMediatingToxic EffectReportingTauopathiesEpitopesAffinityPublishingAntigensPreventAnimalsBaseFuture
Grant awards (57)
Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models$812,712
R01 · FY2025 · NS · contact PI
Epitope-Specific Targeting of Tau Aggregates$677,295
R01 · FY2025 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology$664,193
R01 · FY2025 · AG · contact PI
Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models$812,712
R01 · FY2024 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology$677,747
R01 · FY2024 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates$677,295
R01 · FY2024 · NS · contact PI
Single domain antibodies for diagnosis and treatment of synucleinopathies$717,491
R56 · FY2023 · AG · contact PI
Clearance and In Vivo Detection of Tau Pathology$677,747
R01 · FY2023 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates$677,295
R01 · FY2023 · NS · contact PI
Epitope-Specific Targeting of Tau Aggregates$677,295
R01 · FY2022 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology.$636,762
R01 · FY2022 · AG · contact PI
Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models$2,438,130
RF1 · FY2021 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology.$636,762
R01 · FY2021 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$423,750
R01 · FY2021 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology.$636,762
R01 · FY2020 · AG · contact PI
Tau Pathology and Calcium Dyshomeostasis: Novel Imaging Approach and Therapy$466,125
R21 · FY2020 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$423,750
R01 · FY2020 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology.$636,762
R01 · FY2019 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$423,750
R01 · FY2019 · NS · contact PI
Single Domain Anti-Tau Antibodies as Potential Therapy for Alzheimer's Disease$211,875
R21 · FY2019 · AG · contact PI
Efficacy and Mechanism of Action of Heavy-Chain α-Synuclein Antibody Fragments Derived from Llama$211,875
R21 · FY2019 · AG · contact PI
Research Supplement to Promote Diversity in Health-Related Research$93,256
R01 · FY2019 · AG · contact PI
Clearance and In Vivo Detection of Tau Pathology.$636,762
R01 · FY2018 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$423,750
R01 · FY2018 · NS · contact PI
Efficacy and Mechanism of Action of Heavy-Chain α-Synuclein Antibody Fragments Derived from Llama$254,250
R21 · FY2018 · AG · contact PI
Single Domain Anti-Tau Antibodies as Potential Therapy for Alzheimer's Disease$254,250
R21 · FY2018 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$423,750
R01 · FY2017 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology$347,475
R01 · FY2017 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$449,080
R01 · FY2016 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology$347,475
R01 · FY2016 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$449,080
R01 · FY2015 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology$337,050
R01 · FY2015 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$13,229
R01 · FY2015 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology$347,475
R01 · FY2014 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$356,749
R01 · FY2013 · NS · contact PI
Epitope-Specific Targeting of Tau Aggregates.$356,486
R01 · FY2013 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology$347,475
R01 · FY2013 · AG · contact PI
Clearance and In Vivo Detection of Tau Pathology$329,443
R01 · FY2013 · AG · contact PI
Immune Therapy and Imaging in Mouse and Primate Models of Alzheimer's Disease.$238,069
R01 · FY2013 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$369,688
R01 · FY2012 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology$329,444
R01 · FY2012 · AG · contact PI
Epitope-Specific Targeting of Tau Aggregates.$369,688
R01 · FY2011 · NS · contact PI
Clearance and In Vivo Detection of Tau Pathology$329,444
R01 · FY2011 · AG · contact PI
Immune Therapy and Imaging in Mouse and Primate Models of Alzheimer's Disease$306,659
R01 · FY2011 · AG · contact PI
Clearance and In Vivo Detection of Tau Pathology$342,743
R01 · FY2010 · AG · contact PI
Immune Therapy and Imaging in Mouse and Primate Models of Alzheimer's Disease$319,037
R01 · FY2010 · AG · contact PI
Clearance and In Vivo Detection of Tau Pathology$346,204
R01 · FY2009 · AG · contact PI
Immune Therapy and Imaging in Mouse and Primate Models of Alzheimer's Disease$326,235
R01 · FY2009 · AG · contact PI
Immune Therapy and Imaging in Mouse and Primate Models of Alzheimer's Disease$352,601
R01 · FY2008 · AG · contact PI
Clearance and In Vivo Detection of Tau Pathology$346,118
R01 · FY2008 · AG · contact PI
Immunotherapy for Pancreatic Amylin Aggregates in Diabetes$248,430
R21 · FY2008 · DK · contact PI
Immunotherapy for Pancreatic Amylin Aggregates in Diabetes$211,250
R21 · FY2007 · DK · contact PI
Immune Therapy for AD plaques and Tangles in Tg Mice$295,750
R01 · FY2005 · AG
Immune Therapy for AD plaques and Tangles in Tg Mice$295,750
R01 · FY2004 · AG
Immune Therapy for AD plaques and Tangles in Tg Mice$211,250
R01 · FY2003 · AG
Immune Therapy for AD plaques and Tangles in Tg Mice$210,625
R01 · FY2002 · AG
Immune Therapy for AD plaques and Tangles in Tg Mice$210,000
R01 · FY2001 · AG